Puma Biotechnology
PBYI
PBYI
178 hedge funds and large institutions have $2.42B invested in Puma Biotechnology in 2018 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 83 increasing their positions, 51 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
33% less capital invested
Capital invested by funds: $3.59B → $2.42B (-$1.17B)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
47% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 47
Holders
178
Holding in Top 10
4
Calls
$29.6M
Puts
$38.1M
Top Buyers
| 1 | +$69.4M | |
| 2 | +$56.2M | |
| 3 | +$34M | |
| 4 |
Jennison Associates
New York
|
+$33M |
| 5 |
O
OrbiMed
New York
|
+$31.1M |
Top Sellers
| 1 | -$134M | |
| 2 | -$129M | |
| 3 | -$56M | |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
-$44M |
| 5 |
CCS
Crosspoint Capital Strategies
Orinda,
California
|
-$34.9M |